UTI Large & Mid Cap Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

UTI Large & Mid Cap Fund Growth Fund Overview

Min. investment

SIP ₹500 & Lump. ₹5000

AUM (Fund size)

5,964 Cr

Lock In Period

N/A

Expense Ratio

1.84

Exit Load

For period of holding less than 1 year the exit load charge is 1% of applicable NAV.For period of holding greater than or equal to 1 year the exit load charge is nil.

Benchmark

Nifty Large Midcap 250 Total Return

Summary

UTI Large & Mid Cap Fund Growth NAV is ₹184.0218 as of 23 Jun, 2026. UTI Large & Mid Cap Fund Growth has delivered 65.93% returns since its launch. The minimum SIP investment amount in UTI Large & Mid Cap Fund Growth is ₹500. The AUM of UTI Large & Mid Cap Fund Growth is ₹5,964 Cr. The expense ratio of the fund is 1.84%, and its benchmark is Nifty Large Midcap 250 Total Return. The current exit load of the fund is For period of holding less than 1 year the exit load charge is 1% of applicable NAV.For period of holding greater than or equal to 1 year the exit load charge is nil.. In the last 1M months, UTI Large & Mid Cap Fund Growth has delivered 1.32% returns.

UTI Large & Mid Cap Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M1.320.868.11
6M-1.982.3129.78
1Y3.895.4040.44
3Y18.3915.15134.87

Portfolio Analysis

  • Equity: 93.75%
  • Debt: 4.56%
  • Others
As on: 2026-05-31
View allocation % by

1. HDFC BANK LIMITED4.99%
2. ICICI BANK LTD3.01%
3. FEDERAL BANK LTD.1.81%
4. INDUSIND BANK0.84%

1. INFOSYS LTD.2.82%
2. WIPRO LIMITED2.28%
3. ORACLE FINANCIAL SERVICES SOFT1.63%
4. HCL TECHNOLOGIES LTD.1.54%
5. MPHASIS LTD0.65%

1. AUROBINDO PHARMA LTD.2.34%
2. AJANTA PHARMA LTD.1.19%
3. BIOCON LTD.1.18%
4. CAPLIN POINT LABORATORIES LTD1.09%
5. GLENMARK PHARMACEUTICALS LTD.1.02%
6. MARKSANS PHARMA LTD.0.87%
7. ALEMBIC PHARMACEUTICALS0.35%

1. ADITYA BIRLA CAPITAL LTD1.86%
2. MAX FINANCIAL SERVICES LTD.1.38%
3. MOTILAL OSWAL FINANCIAL SERVIC1.19%

1. PHOENIX MILLS LTD1.68%
2. OBEROI REALTY LIMITED1.47%

1. BHARTI AIRTEL LTD.2.73%

1. STATE BANK OF INDIA1.42%
2. BANK OF MAHARASHTRA1.30%

1. LARSEN & TOUBRO LTD.2.69%

1. ITC LTD.2.67%

1. POWER GRID CORPORATION OF INDI2.56%

1. SHRIRAM FINANCE LTD1.30%
2. SUNDARAM FINANCE LTD.1.26%

1. MARUTI SUZUKI INDIA LTD.1.26%
2. MAHINDRA & MAHINDRA LTD.1.25%

1. LIC OF INDIA1.30%
2. ICICI PRUDENTIAL LIFE INSURA L1.14%

1. RELIANCE INDUSTRIES LTD.2.17%

1. EMAMI LTD.1.04%
2. COLGATE PALMOLIVE INDIA LTD.0.97%

1. INDUS TOWERS LIMITED1.93%

1. GRASIM INDUSTRIES LTD.1.69%

1. HERO MOTOCORP LTD.1.67%

1. COAL INDIA LTD.1.11%
2. VEDANTA LTD0.52%

1. INFO-EDGE (INDIA) LTD.1.53%

1. REC LTD1.47%

1. JUBILANT FOODWORKS LTD.0.96%
2. MAHINDRA HOLIDAYS & RESORTS IN0.50%

1. OIL INDIA LTD.1.45%

1. SUZLON ENERGY LTD.1.43%

1. TUBE INVESTMENTS OF INDIA LTD1.26%

1. TATA POWER COMPANY LTD.1.24%

1. CROMPTON GREAVES CONSUMER ELEC1.18%

1. INTERGLOBE AVIATION LTD1.17%

1. MULTI COMMODITY EXCHANGE OF IN1.07%

1. G R INFRAPROJECTS LTD1.05%

About Fund UTI Large & Mid Cap Fund Growth

UTI Large & Mid Cap Fund Growth managed by UTI Mutual Fund,is a Large and Mid Cap Fundsscheme with Assets Under Management of ₹5,964 Crore. The fund benchmarks its performance against the Nifty Large Midcap 250 Total Return while maintaining an expense ratio of 1.84. Under the expert guidance of V Srivatsa ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

V Srivatsa

Mr. V Srivatsa has done B.Com, CA, ICMA, PGDM. He has been with UTI AMC since 2002. He has around 4 years of experience in the Equity Securities Research handling variety of sectors. Last 4 years in the fund management as fund manager for offshore funds. He is looking after fund management of Hybrid Schemes as an adhoc arrangement and report to Head of Fixed Income. Prior to joining UTI AMC, he has worked with Ford, Rhodes Parks & Co., Chartered Accountants for 3 years and as Officer-Audit in Madras Cements Ltd.

Peer Comparison

Fund Name1Y3Y
This FundICICI Prudential Large & Mid Cap Fund Growth3.317663.7866
This FundQuant Large & Mid Cap Fund Growth8.718564.4986
This FundUTI Large & Mid Cap Fund Growth3.891465.929
This FundInvesco India Large & Mid Cap Fund Growth10.387988.2984
This FundMotilal Oswal Large and Midcap Fund Growth11.018190.198

UTI Large & Mid Cap Fund Growth FAQs

UTI Large & Mid Cap Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of UTI Large & Mid Cap Fund Growth is 1.84. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

UTI Large & Mid Cap Fund Growth’s fund performance is as follows:
  • 1 Month : 1.32%
  • 6 Months : -1.98%
  • 1 Year : 3.89%
  • 3 Years : 18.39%
Returns of UTI Large & Mid Cap Fund Growth are updated daily based on NAV of ₹ 184.0218 as on Jun 22,2026. Since inception, the return has been 65.93%.

You can invest in UTI Large & Mid Cap Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of UTI Large & Mid Cap Fund Growth is ₹5,964 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in UTI Large & Mid Cap Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.